All In Biotech

Drug Trial Radar · NCT00675714

Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

Assessment of the Treatment of the Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

Last checked: Nov 19, 2026Latest source record: Nov 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 1,126 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,126

Actual

Start

Jan 2004

Primary completion

Sep 2018

Study completion Jul 15, 2019

Sponsor

Lead sponsor
The University of Texas Medical Branch, GalvestonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
U.S. Department of Education; National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS)
First posted
May 12, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the program is to study and characterize the outcome of burn injury with particular attention to improving the rehabilitation of burn survivors, including children. Various agents are assessed for effectiveness on long term burn outcome, such as growth hormone, oxandrolone, propranolol,ketoconazole, inhospital exercise and home exercise.

Conditions

  • Burns

Interventions

  • Stable Isotope Infusion StudyProcedure

    1-8 hour stable isotope infusion study to be done following each surgery. Tagged isotopes to assess uptake into blood and tissues.

  • Collection of blood and tissuesProcedure

    Blood draw with each stable isotope infusion study and weekly Tissue biopsy: skin, fat, muscle at stable isotope infusion study

  • Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRIProcedure

    Testing to be done following every stable isotope infusion study to measure muscle, fat and bone tissues.

  • HumatropeDrug

    Humatrope (Growth Hormone) dose:0.05mg - 0.2mg/kg/day SQ daily for up to 2 years post burn injury.

  • KetoconazoleDrug

    Ketoconazole administration (or other glucocorticoid blocker--itraconazole or fluconazole) PO daily for up to 2 years post burn injury

  • OxandroloneDrug

    oxandrolone (or other anabolic steroid-testosterone or nandrolone) daily for up to 2 years post burn injury

  • PropranololDrug

    Propranolol (or other beta adrenergic blocker--metoprolol, inderol), PO administration daily for up to 2 years post burn injury.

  • Oxandrolone and propranolol combinedDrug

    Daily administration of oxandrolone and propranolol to be given for up to 2 years post burn injury.

  • Humatrope and propranolol combinedDrug

    Humatrope (growth hormone) and propranolol administration daily for up to 2 years post burn injury.

  • PlaceboDrug

    placebo to be given once a day for up to two years post burn injury.

  • Exercise--Hospital supervised intensive exercise programBehavioral

    intensive exercise program supervised by trained personnel in the hospital environment for six up to twelve week program.

  • Home exercise programBehavioral

    Home intensive exercise program: training occurs in hospital then patient sent home to continue exercise program for six weeks and up to 12 weeks at home.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Measures of muscle wasting, weakness, immunosuppression chronic bone loss and decreased growth with increases in metabolic, hemodynamic, inflammatory and scarring responses.Time frame: Admission to burn unit and up to 2 years post burn and yearly after that

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Texas Medical Branch

    Galveston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.